What You Should Know:
– Surescripts, the nation’s leading health information network, announced today that TPG Capital, the U.S. and European private equity platform of global alternative asset firm TPG, will become a majority investor.
– This strategic partnership with TPG will enable Surescripts to expand its impact and accelerate the development of innovative solutions that address critical healthcare needs.
Focus on Enhancing Patient Care and Streamlining Processes
TPG’s investment will bolster Surescripts’ capabilities in three key areas:
- Intelligent Prescribing: Improving medication affordability and prescription accuracy.
- Benefits and Authorizations: Streamlining prior authorizations to reduce clinician burden and enhance efficiency.
- Clinical Interoperability: Facilitating seamless data exchange between healthcare providers for better-informed care decisions.
By focusing on these areas, Surescripts aims to alleviate clinician burnout, ensure patients receive the right medications at the best price, and support pharmacists’ evolving role in patient care.
“Surescripts is uniquely poised to address the numerous challenges facing healthcare today and help healthcare heal itself,” said Frank Harvey, Chief Executive Officer for Surescripts. “We are partnering with TPG because of our shared vision for improving healthcare for patients and the clinicians who care for them. TPG’s support will enable us to scale existing solutions while advancing new innovative technologies that will continue to enhance patient safety, lower costs and ensure quality care, amplifying our impact across healthcare.”
